Literature DB >> 28244596

Cardiopulmonary exercise testing improves diagnostic specificity in patients with echocardiography-suspected pulmonary hypertension.

Qin-Hua Zhao1, Lan Wang1, Bigyan Pudasaini1, Rong Jiang1, Ping Yuan1, Su-Gang Gong1, Jian Guo2, Qiang Xiao1, Hui Liu1, Cheng Wu3, Zhi-Cheng Jing4, Jin-Ming Liu1,2.   

Abstract

BACKGROUND: Doppler echocardiography is usually the first diagnostic investigation for patients suspected with pulmonary hypertension (PH), but it is often inaccurate when used alone, especially in mild PH. HYPOTHESIS: Cardiopulmonary exercise testing (CPET) may serve as a complementary tool to improve diagnostic accuracy in echocardiography-suspected "PH possible" patients.
METHODS: Eighty-eight consecutive patients with suspected PH (referred to as "PH possible" hereafter) based on echocardiography were included in the study. CPET was assessed subsequently and PH was confirmed by right-heart catheterization in all subjects. We analyzed CPET data from patients and derived a CPET prediction rule to hemodynamically differentiate PH.
RESULTS: Eighty-eight patients (27 patients with confirmed PH, and PH ruled out in 61 patients) were included in the study. Compared with non-PH patients, the PH subjects had lower peak oxygen uptake (VO2 ), aerobic capacity (AT), peak partial pressure of end-tidal CO2 (PET CO2 ), oxygen uptake efficiency plateau (OUEP), and oxygen uptake efficiency slope (OUES), along with higher minute ventilation (VE)/carbon dioxide output (VCO2 ) slope and lowest VE/VCO2 (P < 0.001). VE/VCO2 slope and AT were independent predictors of PH derived from multivariate logistic regression adjusted for age and body mass index. A score combining VE/VCO2 slope and AT reached a high area under the curve value of 0.98. A score ≥0.5 had 95% specificity and 92.6% sensitivity for diagnosis of PH.
CONCLUSIONS: A score combining VE/VCO2 slope and AT provides high specificity in screening out PH from a pool of echocardiography-suspected PH patients.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Imaging; Pulmonary hypertension; cardiopulmonary exercise testing; diagnostic procedures; echocardiography

Mesh:

Year:  2016        PMID: 28244596      PMCID: PMC6490376          DOI: 10.1002/clc.22635

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  25 in total

1.  Feasibility and accuracy of a routine echocardiographic assessment of right ventricular function.

Authors:  Gloria Tamborini; Mauro Pepi; Claudia Agnese Galli; Anna Maltagliati; Fabrizio Celeste; Manuela Muratori; Salehi Rezvanieh; Fabrizio Veglia
Journal:  Int J Cardiol       Date:  2006-06-05       Impact factor: 4.164

2.  Cardiopulmonary exercise testing and six-minute walk correlations in pulmonary arterial hypertension.

Authors:  Ronald J Oudiz; Robyn J Barst; James E Hansen; Xing-Guo Sun; Robert Garofano; Xionghua Wu; Karlman Wasserman
Journal:  Am J Cardiol       Date:  2005-11-10       Impact factor: 2.778

3.  Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.

Authors:  Eric Hachulla; Virginie Gressin; Loïc Guillevin; Patrick Carpentier; Elisabeth Diot; Jean Sibilia; André Kahan; Jean Cabane; Camille Francès; David Launay; Luc Mouthon; Yannick Allanore; Kiet Phong Tiev; Pierre Clerson; Pascal de Groote; Marc Humbert
Journal:  Arthritis Rheum       Date:  2005-12

4.  Exercise pathophysiology in patients with primary pulmonary hypertension.

Authors:  X G Sun; J E Hansen; R J Oudiz; K Wasserman
Journal:  Circulation       Date:  2001-07-24       Impact factor: 29.690

5.  End-tidal PCO2 abnormality and exercise limitation in patients with primary pulmonary hypertension.

Authors:  Yuji Yasunobu; Ronald J Oudiz; Xing-Guo Sun; James E Hansen; Karlman Wasserman
Journal:  Chest       Date:  2005-05       Impact factor: 9.410

6.  Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing.

Authors:  S Miyamoto; N Nagaya; T Satoh; S Kyotani; F Sakamaki; M Fujita; N Nakanishi; K Miyatake
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

7.  Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

Authors:  Michael McGoon; David Gutterman; Virginia Steen; Robin Barst; Douglas C McCrory; Terry A Fortin; James E Loyd
Journal:  Chest       Date:  2004-07       Impact factor: 9.410

Review 8.  Pathologic assessment of vasculopathies in pulmonary hypertension.

Authors:  Giuseppe G Pietra; Frederique Capron; Susan Stewart; Ornella Leone; Marc Humbert; Ivan M Robbins; Lynne M Reid; R M Tuder
Journal:  J Am Coll Cardiol       Date:  2004-06-16       Impact factor: 24.094

9.  Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing.

Authors:  Roland Wensel; Christian F Opitz; Stefan D Anker; Jörg Winkler; Gert Höffken; Franz X Kleber; Rakesh Sharma; Manfred Hummel; Roland Hetzer; Ralf Ewert
Journal:  Circulation       Date:  2002-07-16       Impact factor: 29.690

10.  Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis.

Authors:  D Mukerjee; D St George; C Knight; J Davar; A U Wells; R M Du Bois; C M Black; J G Coghlan
Journal:  Rheumatology (Oxford)       Date:  2004-01-06       Impact factor: 7.580

View more
  4 in total

1.  Ventilatory power, a cardiopulmonary exercise testing parameter for the prediction of pulmonary hypertension at right heart catheterization.

Authors:  Michele Correale; Ilenia Monaco; Armando Ferraretti; Lucia Tricarico; Monica Sicuranza; Anna Maria Gallotta; Ennio Sascia Formica; Gianfranco Acanfora; Matteo Di Biase; Natale Daniele Brunetti
Journal:  Int J Cardiol Heart Vasc       Date:  2020-04-21

2.  Screening strategies for pulmonary arterial hypertension.

Authors:  David G Kiely; Allan Lawrie; Marc Humbert
Journal:  Eur Heart J Suppl       Date:  2019-12-17       Impact factor: 1.803

3.  The value of cardiopulmonary exercise testing in the diagnosis of pulmonary hypertension.

Authors:  Qin Luo; Xue Yu; Zhihui Zhao; Qing Zhao; Xiuping Ma; Qi Jin; Lu Yan; Yi Zhang; Zhihong Liu
Journal:  J Thorac Dis       Date:  2021-01       Impact factor: 2.895

4.  Role of cardiopulmonary exercise test in the prediction of hemodynamic impairment in patients with pulmonary arterial hypertension.

Authors:  B Pezzuto; R Badagliacca; M Muratori; S Farina; M Bussotti; M Correale; A Bonomi; C Vignati; S Sciomer; S Papa; E Palazzo Adriano; P Agostoni
Journal:  Pulm Circ       Date:  2022-03-24       Impact factor: 2.886

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.